← Back to Search

Other

Selective Cytopheretic Device for Cardio-Renal Syndrome

N/A
Waitlist Available
Research Sponsored by Lenar Yessayan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from onset of intervention to 3 and 6 days after initiation of scd treatments and from onset of intervention to end of scd support prior to lvad implantation
Awards & highlights

Study Summary

This trial will study whether using the SCD device can help to improve heart and kidney function in people with congestive heart failure who also have cardiorenal syndrome, and are awaiting LVAD implantation.

Eligible Conditions
  • Cardio-Renal Syndrome
  • Congestive Heart Failure

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from onset of intervention to 3 and 6 days after initiation of scd treatments and from onset of intervention to end of scd support prior to lvad implantation
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from onset of intervention to 3 and 6 days after initiation of scd treatments and from onset of intervention to end of scd support prior to lvad implantation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent of patients with reversal of Worsening Renal Function (WRF)
Secondary outcome measures
Change in 24 hour urine volume
Change in Pulmonary Capillary Wedge Pressure (PCWP)
Change in blood urea nitrogen (BUN)
+12 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Selective Cytopheretic DeviceExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Lenar YessayanLead Sponsor
2 Previous Clinical Trials
20 Total Patients Enrolled
1 Trials studying Cardio-Renal Syndrome
10 Patients Enrolled for Cardio-Renal Syndrome
Keith Aaronson, MDLead Sponsor
1 Previous Clinical Trials
10 Total Patients Enrolled
1 Trials studying Cardio-Renal Syndrome
10 Patients Enrolled for Cardio-Renal Syndrome

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial presently enlisting participants?

"Per the information accessible on clinicaltrials.gov, this medical trial is currently in search of participants. It was first announced on November 11th 2019 and its contents were last revised October 31st 2022."

Answered by AI

What is the aggregate participation rate of this clinical experiment?

"Affirmative. The information on clinicaltrials.gov verifies that the research project, which was initially posted on November 11th 2019, is actively enlisting participants. 10 individuals are needed for enrolment at a single trial centre."

Answered by AI

What class of participants is best suited for this research?

"To take part in this research, individuals must be between 21 and 75 years old with a diagnosis of heart failure. In total the team hopes to recruit 10 participants for their study."

Answered by AI

Is this experiment available for septuagenarians?

"The required age range for this study is between 21 and 75 years old."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Selective Cytopheretic Device (SCD) Trial
Lenar Yessayan 2019. "Selective Cytopheretic Device (SCD) Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03836482.
~1 spots leftby Feb 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top